Nuvectis Pharma (NVCT) Stock Chart & Stock Price History $7.96 -0.17 (-2.09%) Closing price 04:00 PM EasternExtended Trading$7.98 +0.02 (+0.25%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nuvectis Pharma Stock Price Performance The Nuvectis Pharma (NVCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 12.91%, with a year-to-date return of 47.13%. In the past month, the stock has decreased 19.02%, reflecting recent market activity. As of the latest close, Nuvectis Pharma traded at $8.13 with a market cap of $169.87 million and volume of 93,851 shares. Receive NVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.12%1 Month Performance-19.02%3 Month Performance-21.96%Year-To-Date Performance+47.13%1 Year Performance+12.91% NVCT Stock Chart for Monday, June, 23, 2025 NVCT Chart by TradingView Nuvectis Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/23/2025$8.13$7.96-2.09%$8.27$7.84116,327 shs$166.28 million06/20/2025$8.05$8.13+0.99%$8.20$7.9093,851 shs$169.87 million06/19/2025$8.05$8.05$8.33$7.91103,552 shs$168.16 million06/18/2025$8.11$8.05-0.74%$8.33$7.91103,552 shs$168.16 million06/17/2025$8.64$8.11-6.13%$8.86$8.1184,913 shs$169.45 million06/16/2025$8.41$8.64+2.73%$8.89$8.3679,296 shs$180.52 million06/13/2025$8.83$8.41-4.76%$8.95$8.40122,453 shs$175.72 million06/12/2025$8.83$8.83$9.20$8.6166,584 shs$184.49 million06/11/2025$9.02$8.83-2.11%$9.30$8.81106,854 shs$184.49 million06/10/2025$8.85$9.02+1.92%$9.07$8.5041,363 shs$188.46 million Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 06/09/2025$8.85$8.85$8.93$8.5072,760 shs$184.91 million06/06/2025$8.97$8.85-1.34%$9.14$8.83125,500 shs$184.91 million06/05/2025$8.86$8.97+1.24%$9.00$8.7950,477 shs$187.42 million06/04/2025$8.94$8.86-0.89%$9.33$8.81103,162 shs$185.12 million06/03/2025$8.98$8.94-0.45%$9.15$8.65151,430 shs$186.79 million06/02/2025$9.17$8.98-2.07%$9.75$8.93149,556 shs$187.63 million05/30/2025$9.35$9.17-1.93%$9.54$9.1571,872 shs$191.60 million05/29/2025$9.66$9.35-3.21%$9.83$9.25150,399 shs$195.36 million05/28/2025$9.66$9.66$9.87$9.4174,092 shs$201.84 million05/27/2025$9.83$9.66-1.73%$10.17$9.66100,702 shs$201.84 million05/26/2025$9.83$9.83$10.32$9.8283,412 shs$205.39 million05/23/2025$9.95$9.83-1.21%$10.32$9.8283,412 shs$205.39 million05/22/2025$10.05$9.95-1.00%$10.33$9.95113,939 shs$207.90 million Related Companies XERS Stock Price Chart ABUS Stock Price Chart AVXL Stock Price Chart ANAB Stock Price Chart DAWN Stock Price Chart GHRS Stock Price Chart KALV Stock Price Chart XNCR Stock Price Chart EOLS Stock Price Chart STOK Stock Price Chart Receive NVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NVCT) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
